These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1407583)

  • 1. Valproate acute administration, EEG epileptic abnormalities, and ammonemia.
    Sannita WG
    Neurology; 1992 Oct; 42(10):2003-5. PubMed ID: 1407583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sodium valproate: a hyperammonemic drug. Study in the epileptic and healthy volunteer].
    Marescaux C; Warter JM; Laroye M; Rumbach L; Micheletti G; Koehl C; Imler M; Kurtz D
    J Neurol Sci; 1983 Feb; 58(2):195-209. PubMed ID: 6403673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ammonia-independent modifications of the background EEG signal and paradoxical enhancement of epileptic abnormalities in EEG after acute administration of valproate to epileptic patients.
    Sannita WG; Balestra V; DiBon G; Hassan KM; Rosadini G
    Neuropharmacology; 1993 Sep; 32(9):919-28. PubMed ID: 8232792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of significant correlation between circadian profiles of valproic acid serum levels and epileptiform electroencephalographic activity.
    Burr W; Froescher W; Hoffmann F; Stefan H
    Ther Drug Monit; 1984; 6(2):179-81. PubMed ID: 6429910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperaminoacidemia in epileptic children treated with valproic acid.
    Castro-Gago M; Rodrigo-Saez E; Novo-Rodriguez I; Camiña MF; Rodriguez-Segade S
    Childs Nerv Syst; 1990 Dec; 6(8):434-6. PubMed ID: 2095300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral analysis of the EEG in children during the introduction of antiepileptic therapy with valproic acid.
    Benninger C; Matthis P; Scheffner D
    Neuropsychobiology; 1985; 13(1-2):93-6. PubMed ID: 3929157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
    Ettlin T; Scollo-Lavizzari G
    Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
    [No Abstract]   [Full Text] [Related]  

  • 8. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
    Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
    No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases.
    Zaccara G; Paganini M; Campostrini R; Arnetoli G; Zappoli R; Moroni F
    Eur Neurol; 1984; 23(2):104-12. PubMed ID: 6426961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-induced hyperammonaemia in two epileptic identical twins.
    Campostrini R; Zaccara G; Rossi L; Paganini M; Dorigotti A; Zappoli R
    J Neurol; 1985; 232(3):167-8. PubMed ID: 3928828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.
    Iinuma K; Hayasaka K; Narisawa K; Tada K; Hori K
    Eur J Pediatr; 1988 Dec; 148(3):267-9. PubMed ID: 3145882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC
    Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
    Thom H; Carter PE; Cole GF; Stevenson KL
    Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate hepatotoxicity: a review and report of two instances in adults.
    Dickinson RG; Bassett ML; Searle J; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1985; 21():79-91. PubMed ID: 3939614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-associated hyperammonemia and DL-carnitine supplement.
    Komatsu M; Kodama S; Yokoyama S; Konishi H; Tanaka K; Momota K; Wada H; Matsuo T
    Kobe J Med Sci; 1987 Jun; 33(3):81-7. PubMed ID: 2959815
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
    Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
    Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood ammonia level during valproic acid therapy.
    Kugoh T; Yamamoto M; Hosokawa K
    Jpn J Psychiatry Neurol; 1986 Dec; 40(4):663-8. PubMed ID: 3110472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of hyperammonemia in stuporous states induced by sodium valproate].
    Warter JM; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Koehl C; Imler M; Collard M
    Rev Neurol (Paris); 1983; 139(12):753-7. PubMed ID: 6420866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.